Crossover RCT in 20 adults with insomnia disorder: a single dose of cannabinol 30 mg or 300 mg did not significantly change wake after sleep onset vs placebo (300 mg: -6.3 min, p=0.29). 300 mg improved some secondary measures; 247 mild-to-moderate adverse events.
RCTn = 20
Lavender et al. Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial